Core Scientific Inc (CORZ) Peer Comparison
$14.38
$-0.19
(-1.30%)
As on 12-Nov-2026 16:08EST
Market cap
$3,779 Mln
Revenue (TTM)
$592 Mln
P/E Ratio
--
P/B Ratio
0
Div. Yield
0 %
Edit
| Core Scientific Inc (CORZ) | Atlas Crest Investment Corp (ACIC) | TPG Inc (TPG) | Blue Owl Capital Inc. Class A (OWL) | Carlyle Group Inc (CG) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
3,779 | 475 | 17,898 | 15,499 | 14,146 |
Revenue ($ Mln) |
592 | 311 | 5,171 | 3,069 | 3,516 |
Net Profit ($ Mln) |
-110.22 | 87.11 | 268.72 | 94.56 | 286.20 |
Net Margin (%) |
-18.62 | 28.03 | 5.20 | 3.08 | 8.14 |
RoE (%) |
-- | 25.35 | -16.51 | -9.05 | 3.68 |
Price to Earnings |
-- | 5.70 | 52.84 | 70.64 | 40.93 |
Price-To-Book |
-- | 1.33 | 6.23 | 3.84 | 2.71 |
Income Statement ($ Mln)
| Core Scientific Inc (CORZ) | Atlas Crest Investment Corp (ACIC) | TPG Inc (TPG) | Blue Owl Capital Inc. Class A (OWL) | Carlyle Group Inc (CG) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
592.07 | 310.79 | 5,170.78 | 3,068.99 | 3,516.30 |
|
Cost of Revenue
|
348.26 | 62.96 | 241.69 | 1,297.02 | 955.20 |
|
Gross Profit
|
37.90 | 289.40 | 4,522.82 | 1,589.45 | 3,229.10 |
|
Operating Expenses
|
254.46 | 131.10 | 3,989.56 | 1,061.00 | 1,749.20 |
|
Operating Profit (EBIT)
|
-10.51 | 116.74 | 939.52 | 710.97 | 671.60 |
|
Other Income
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
Profit before Tax
|
-214.12 | 116.74 | 901.20 | 428.78 | 479.70 |
|
Provision for Tax
|
-103.90 | 29.63 | 158.54 | 57.55 | 128.10 |
|
Profit after Tax (Net Income)
|
-110.22 | 87.11 | 268.72 | 94.56 | 286.20 |
|
Minority Interest
|
0.00 | 0.00 | -473.94 | -276.67 | -65.40 |
|
Consolidated Profit
|
0.00 | 0.00 | 0.00 | 47.67 | 0.00 |
Liabilities ($ Mln)
| Core Scientific Inc (CORZ) | Atlas Crest Investment Corp (ACIC) | TPG Inc (TPG) | Blue Owl Capital Inc. Class A (OWL) | Carlyle Group Inc (CG) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
-1,092.08 | 355.68 | 1,352.00 | 1,922.69 | 6,596.60 |
|
Minority Interest
|
0.00 | 0.00 | -473.94 | -276.67 | -65.40 |
|
Non-Current Liabilities
|
4,920.58 | 523.83 | 10,716.03 | 6,293.83 | 21,224.20 |
|
Current Liabilities
|
2,107.21 | 0.00 | 0.00 | 523.55 | 358.60 |
|
Total Liabilities
|
2,347.64 | 1,072.73 | 13,492.94 | 12,467.68 | 29,116.00 |
Assets ($ Mln)
| Core Scientific Inc (CORZ) | Atlas Crest Investment Corp (ACIC) | TPG Inc (TPG) | Blue Owl Capital Inc. Class A (OWL) | Carlyle Group Inc (CG) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
4,513.56 | 64.95 | 13,883.49 | 10,126.29 | 1,045.30 |
|
Current Assets
|
1,422.15 | 345.90 | 799.79 | 213.61 | 2,599.40 |
|
Total Assets
|
2,347.64 | 1,072.73 | 13,492.94 | 12,467.68 | 29,116.00 |
|
Total Debt*
|
4,406.80 | 152.57 | 2,279.49 | 523.55 | 0.00 |
|
Net Current Assets
|
0.00 | 0.00 | 0.00 | 813.96 | 0.00 |
Cashflow ($ Mln)
| Core Scientific Inc (CORZ) | Atlas Crest Investment Corp (ACIC) | TPG Inc (TPG) | Blue Owl Capital Inc. Class A (OWL) | Carlyle Group Inc (CG) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
278.25 | 71.03 | 1,032.40 | 1,256.03 | 1,462.90 |
|
Cash Flow from Investing Activities
|
-740.75 | 0.62 | -263.96 | -270.57 | -4,245.40 |
|
Cash from Financing Activities
|
-63.10 | -1.08 | -750.36 | -943.04 | 3,278.70 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Core Scientific Inc (CORZ) | Atlas Crest Investment Corp (ACIC) | TPG Inc (TPG) | Blue Owl Capital Inc. Class A (OWL) | Carlyle Group Inc (CG) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
-120.97 | 24.90 | 7.00 | 1.41 | 4.65 |
|
ROE (%)
|
32.38 | 25.35 | -16.51 | -9.05 | 3.68 |
|
ROA (%)
|
-2.14 | 5.80 | 1.79 | 0.76 | 0.92 |
|
EBIT Margin (%)
|
-25.24 | 31.57 | 18.71 | 20.28 | 19.10 |
|
Net Margin (%)
|
-18.62 | 28.03 | 5.20 | 3.08 | 8.14 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| Core Scientific Inc (CORZ) | Atlas Crest Investment Corp (ACIC) | TPG Inc (TPG) | Blue Owl Capital Inc. Class A (OWL) | Carlyle Group Inc (CG) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
77.17 | -5.18 | 70.99 | 11.76 | -4.74 |
|
EBIT Growth (%)
|
-203.96 | -22.09 | 151.87 | 51.93 | -30.23 |
|
Net Profit Growth (%)
|
85.74 | 2.22 | 161.88 | 82.17 | -56.73 |
|
EPS Growth (%)
|
46.36 | 2.87 | 158.15 | 64.82 | -58.48 |
|
Book Value Growth (%)
|
34.24 | 12.08 | 15.99 | -19.27 | 24.74 |
Valuation Ratios
| Core Scientific Inc (CORZ) | Atlas Crest Investment Corp (ACIC) | TPG Inc (TPG) | Blue Owl Capital Inc. Class A (OWL) | Carlyle Group Inc (CG) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-19.80 | 5.90 | 131.78 | 125.99 | 27.33 |
|
Price / Book Value
|
-5.94 | 1.99 | 20.52 | 4.50 | 3.84 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
-31.10 | 2.94 | 30.30 | 14.53 | 22.23 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Core Scientific Inc (CORZ) | Atlas Crest Investment Corp (ACIC) | TPG Inc (TPG) | Blue Owl Capital Inc. Class A (OWL) | Carlyle Group Inc (CG) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.00 | 0.00 | 0.00 | 1.89 | 0.00 |
|
Short term debt to equity ratio
|
-0.01 | 0.00 | 0.00 | 0.27 | 0.00 |
|
Current Ratio
|
0.67 | 1.22 | 0.15 | 0.41 | 7.25 |
|
Quick Ratio
|
0.67 | -- | -- | 0.41 | 7.25 |
|
Interest Coverage
|
-2.31 | 13.04 | 7.68 | 3.35 | 2.56 |
Operating Efficiency Ratios
| Core Scientific Inc (CORZ) | Atlas Crest Investment Corp (ACIC) | TPG Inc (TPG) | Blue Owl Capital Inc. Class A (OWL) | Carlyle Group Inc (CG) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
47.74 | 16.48 | 0.00 | 25.61 | 28.89 |
|
Asset Turnover
|
0.11 | 0.21 | 0.35 | 0.25 | 0.11 |
|
Receivable days
|
193.60 | 281.90 | 34.98 | 83.79 | 77.70 |
|
Inventory Days
|
-- | -- | -- | -- | -- |
|
Payable days
|
94.44 | 1,383.94 | 116.92 | 45.16 | -- |
|
Cash Conversion Cycle
|
-- | -- | -- | -- | -- |
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
